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Species and biotype distribution was determined in 44 bovine viral diarrhea virus- (BVDV-) positive samples submitted to the
Animal Disease Diagnostic Laboratory (ADDL) in Indiana during 2006–2008. BVDV RNA was detected in the 5 -untranslated
region and Npro region using reverse transcriptase PCR followed by sequencing analysis of the PCR product. Additionally, cases
were classiﬁedinto one ofsix categories according to history and/orlesions:acute symptomatic, hemorrhagic,respiratory distress,
reproductive, persistent infection(PI),andmucosaldisease(MD).Of44BVDV-positivesamples,33were noncytopathic(ncp),10
were cytopathic (cp), and onepresented both ncp and cp biotypes. Sequencing analysisdemonstrated that all samples belonged to
BVDV-1a, BVDV-1b, or BVDV-2. The most common isolate was ncp BVDV-1b, (44%) followed by ncp BVDV-2a (24%). Among
the six categories, respiratory clinical signs were the most common (36%) followed by PI (25%) and MD (16%).
1.Introduction
F o ro v e rh a l fac e n t u r y ,b o v i n ev i r a ld i a r r h e av i r u s( B V D V )
has been known to cause signiﬁcant disease in cattle herds
and other ruminant populations worldwide, creating a
substantial economic impact on both the beef and dairy
industries [1].
Two types of BVDV infection are recognized in the lit-
erature: acute or transient infection and persistent infection
(PI) [2]. Na¨ ıve animals infected with BVDV develop acute
infection, clearing the virus from the body within 7–21 days
and develop lifelong antibodies [3]. On the other hand, PI
resultsasaconsequenceoffetalinfectionbetween18and125
daysofgestationwith thefetusbecomingimmunotolerantto
thevirus[4].Ifborn,PIanimals areBVDVantibody negative
and BVDV positive, shedding large amounts of virus, and
animals are viremic during their lifetime. In addition, PI
animals may develop mucosal disease (MD) if they are
superinfected with a homologous cytopathic (cp) strain of
BVDV, orthrough a mutationoftheinfecting ncpBVD virus
to the cp form [5]. In both types of infection, clinical signs
vary between asymptomatic through mild transient signs to
severe acute disease with signs from enteric, hematopoietic,
reproductive,orrespiratory systems. Asevereformofclinical
disease, later named hemorrhagic syndrome, was described
for the ﬁrst time during the 1990s associated with BVDV-2
[6]. This syndrome was characterized by fever, pneumonia,
diarrhea, and lesions similar to the mucosal disease lesions,
death [7]. Not all BVDV-2 species are associated with this
severe form of clinical disease [8].
BVDV strains are classiﬁed into two species within the
pestiviruses and two biotypes [9]. BVDV species classiﬁca-
tion is done by analyzing the 5 -untranslated region (5 -
UTR) and the Npro region of the viral genome [10, 11].
Each BVDV species is divided into subgroups and currently
11 BVDV-1 and 2 BVDV-2 subgroups have been identiﬁed.
Most authors agree that BVDV-1 is the most common isolate
in the United States [12–15], although one study reported
that, in the northwest of the US, BVDV-2 was the most
common isolate1 [16]. In addition, each species is classiﬁed
as one of two biotypes according to its ability to induce2 Veterinary Medicine International
changes in cell cultures [17]. Cytopathic (cp) viruses are
capableofcausingcelldeathincellculture,alsoknownasthe
cytopathic eﬀect (CPE); noncytopathic (ncp) viruses do not
induce any visible cell changes [17]. Of these two biotypes,
ncp viruses are more commonly isolated from ﬁeld cases
when compared to cp viruses [12, 14].
The objective of this study was to determine the biotype
and species distribution of BVDV-positive samples submit-
ted to the Indiana Animal Disease Diagnostic Laboratory
(ADDL) from 2006 to 2008. A second objective was to
correlate the biotype and species to the reported history and
lesions in each case.
2.MaterialandMethods
Forty-four BVDV-positive samples submitted to ADDL dur-
ing 2006–2008 for BVDV diagnosis were included in this
study. Samples submitted included buﬀy coat, serum, fetus,
placenta, brain, lung, mouth, esophagus, oral mucosa, oral
tissue pool, mesenteric lymph nodes, thymus, coronary
band, and intestine. Samples were inoculated in Madin-
Darby bovine kidney (MDBK) cells and cultured in 48-well
plates using 5% horse serum, 20mM L-glutamine, and gen-
tamicin 100ug/mL incubated at 37◦C( 5 %C O 2 incubator)
for three days. During this time cells were observed daily and
CPE was recorded. Cell cultures in 48-well plates were ﬁxed
in 80% aqueous acetone, and the presence of the virus in
the cell culture was detected by indirect ﬂuorescent antibody
assay using ﬂuorescein isothiocyanate- (FITC-) labeled poly-
clonal antibodies raised against BVDV as described in [12].
Supernatants were harvested from inoculated plates, and
viral RNA was extracted using a commercial kit (MagAttract
Virus Mini M48 Kit (QIAGEN, Calif, USA)) and instrument
(KingFisherinstrument(ThermoFisherScientiﬁcInc.,Mass,
USA)), followed by reverse transcriptase polymerase chain
reaction (RT-PCR). The ﬁrst set of primers used in the RT-
PCR reaction, 103/326, ampliﬁed viral RNA in the 5 -UTR
as described with some modiﬁcation in [18]. The second set
of primers, BD1/BD3, were utilized in this study to amplify
viral RNA in the Npro region as described in [19]. Samples
that appeared negative for viral RNA in the Npro region were
retested by RT-PCR using primers BD1/BD4 [19].
The ampliﬁed PCR products were puriﬁed using a com-
mercial puriﬁcation kit (QIAGEN (QIAGEN, Calif, USA))
according to the manufacturer’s protocol. These products
weresequenced,usinganautomatedsequenceratthePurdue
genomic core facilities, and analyzed, and their homology
to other BVD viruses was determined based on published
sequence information and reference control viruses. This
analysis was performed by using computer software (DNAS-
TAR (Madison, Wis USA)). The 5 -UTR and the Npro ge-
nome sequences of BVD viral isolates were evaluated for
further subgenotype classiﬁcation and compared to known
BVDV reference sequence information to developa phyloge-
netic tree (Figures 1 and 2).
Based on reported history and lesions, each case was
assigned into one of the following six categories: acute
symptomatic, hemorrhagic, respiratory distress, reproduc-
Table 1: Biotype and subgenotype distribution of BVDV samples
submitted to IndianaAnimalDiseaseDiagnosticLaboratoryduring
2006–2008.
Biotype Subgenotype
BVDV 1a BVDV 1b BVDV 2a
ncp∗ 31 9 1 1
cp† 415
ncp and cp 0 1 0
∗Noncytopathic
†Cytopathic.
tive, persistent infection (PI), or mucosal disease (MD). A
case was classiﬁed into the PI category if this was a second
sample submission based on a previous positive result from
our laboratory or if it was provided in the case history. A
case was classiﬁed as mucosal disease if there were gross or
histopathological lesions characteristic of mucosal disease as
well as isolation of the cp biotype. Cases were assigned to
the other 4 categories based on what has been previously
described in [20].
3.Results
A total of 44 BVDV-positive samples from 27 of Indiana’s
94 (29%) counties submitted to ADDL during 2006–2008
were included in this study. The ncp biotype was most
commonly isolated comprising 33 (75%) of the 44 positive
cases, followed by the cp biotype in 10 (22.7%) out of the
44 cases and ﬁnally one case (2.3%) in which both biotypes
were isolated. Genetic analysis revealed that a total of three
subgenotypes were present among these samples: BVDV-
1a (16%), BVDV-1b (48%), and BVDV-2a (36%). Most of
the samples were classiﬁed as ncp BVDV-1b (44%) and ncp
BVDV-2a (24%) (Table 1). The most common BVDV infec-
tion was associated with respiratory signs which comprised
36% of the cases, followed by PI in 26% of the cases.
In most of the cases categorized with respiratory clinical
signs there were also other bacterial pathogens isolated that
are commonly associated with bovine respiratory disease
(BRD): Arcanobacterium pyogenes, Haemophilus somnus,
Mycoplasma spp., Mannheimia haemolytica,a n dPasteurella
multocida. Vaccine history was not provided for all cases; 6
cases (13.7%) received a BVDV killed vaccine and 6 cases
received a BVDV modiﬁed live (MLV) vaccine. In the case of
MLV vaccines, if available, the vaccine strain sequence was
compared in the Npro and 5 -UTR sequence region to the
case isolate. Only one virus from a case had 99.6% homology
to the vaccine strain, NADL.
4.Discussion
This study determined that there exist several species and
biotypes of the BVD virus from isolates across Indiana from
2006 to 2008 and supported the fact that there is wide
diversity among BVDV strains. This paper is in accordance
with previous reports in which the three most commonVeterinary Medicine International 3
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Figure 1: Phylogenetic tree of pestiviruses sequenced at 5 -UTR from cattle isolate samples submitted to the Indiana Animal Disease
Diagnostic Laboratory between 2006 and 2008 compared to reference BVD viruses constructed by DNASTAR program, using Clustal W
method.
subgenotypes isolated in the USA are BVDV-1a, BVDV-1b,
and BVDV-2a, with BVDV-1b being the most common iso-
late [12–15].
Cases were most commonly categorized with respiratory
clinical signs in this study. BVDV contributes to BRD as
both a primary pathogen and immunosuppressor predis-
posing the animal to secondary bacterial infections [21–
23]. In particular, BVDV-1 has been associated with BRD,
speciﬁcally, BVDV-1b which was predominantly isolated
from calves with respiratory disease [24]. However, in this
study we cannot determine that there was an association
of subgenotypes with particular clinical signs. From one4 Veterinary Medicine International
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Figure 2: Phylogenetic tree of pestiviruses sequenced at Npro region from cattle isolated from samples submitted to the Indiana Animal
DiseaseDiagnosticLaboratorybetween 2006and2008comparedtoreference BVDvirusesconstructed byDNASTAR program,usingClustal
Wm e t h o d .
respiratory case that was given an MLV vaccine, the isolated
BVDV strain was homologous to the vaccine strain.
Animals categorized with persistent infections were
based on previous submissions to our laboratory from the
samecaseorfromthehistoryprovidedbytheclinician.How-
ever, this number of PI cases could be an underestimation
for two reasons: ﬁrst, there is a possibility that PI animals
were categorized into a diﬀerent category because the PI
diagnosis could not be made based on a single virus isola-
tion ﬁnding, and, second, animals categorized as mucosal
disease may have been PI animals at the beginning of
disease.Veterinary Medicine International 5
As stated in previous studies, the majority of the vaccines
available include either BVDV-1a only or BVDV-1a and
BVDV-2a and, to the best of our knowledge, there is only
one BVDV vaccine that includes BVDV-1b [11, 25]. The
fact that BVDV-1b has been shown to be the most common
isolate in the USA and evidence showing that BVDV-
1a vaccines induce lower antibody titers against BVDV-
1b when compared to BVDV-1a antibody titers raise the
question of adequate protection from the vaccines available
[25]. However, it is not known to what degree there is
cross-reactivity between subgenotypes. Future successful
BVDV eradication and control programs will rely on the
development of new vaccines and current ongoing research
and diagnostic work at Purdue Indiana ADDL and other
laboratories.
Acknowledgment
The authors would like to thank the staﬀ of the virology
section in Indiana ADDL for help and support throughout
this study.
References
[1] D. Deregt, “BVD introduction and history,” in Bovine Viral
Diarrhea Virus Diagnosis, Management and Control,S .M .R .
J. Goyal, Ed., pp. 3–33, Blackwell, Oxford, UK, 2005.
[2] J. C. Baker, “The clinical manifestations of bovine viral
diarrhea infection,” Veterinary Clinics of North America. Food
Animal Practice, vol. 11, no. 3, pp. 425–445, 1995.
[3] P. F. Nettleton and G. Entrican, “Ruminant pestiviruses,”
British Veterinary Journal, vol. 151, no. 6, pp. 615–642, 1995.
[4] C. L. Kelling, “Evolution of bovine viral diarrhea virus
vaccines,” Veterinary Clinics of North America. Food Animal
Practice, vol. 20, no. 1, pp. 115–129, 2004.
[ 5 ]S .R .B o l i n ,“ T h ep a t h o g e n e s i so fm u c o s a ld i s e a s e , ”Veterinary
Clinics of North America. Food Animal Practice, vol. 11, no. 3,
pp. 489–500, 1995.
[6] J .F .Ridpath,J .D .N eill,S.V ilc ek,E.J .Dubovi,andS.Carman,
“Multiple outbreaks of severe acute BVDV in North America
occurring between 1993 and 1995 linked to the same BVDV2
strain,”Veterinary Microbiology,vol.114,no.3-4,pp.196–204,
2006.
[7] S. Carman, T. Van Dreumel, J. Ridpath et al., “Severe acute
bovine viral diarrhea in Ontario, 1993–1995,” Journal of
Veterinary Diagnostic Investigation, vol. 10, no. 1, pp. 27–35,
1998.
[8] E. M. Liebler-Tenorio, J. F. Ridpath, and J. D. Neill, “Dis-
tribution of viral antigen and development of lesions after
experimental infection of calves with a BVDV 2 strain of
low virulence,” Journal of Veterinary Diagnostic Investigation,
vol. 15, no. 3, pp. 221–232, 2003.
[9] C .M.F au q u e t ,M.A .M a y o ,J .M aniloﬀet al.,“Flaviviridae,” in
Virus Taxonomy: Eight Report of the International Committee
on Taxonomy of Viruses, Elsevier Academic Press, Amsterdam,
The Netherlands, 2005.
[10] R. Avalos-Ramirez, M. Orlich, H. J. Thiel, and P. Becher,
“Evidence for the presence of two novel Pestivirus species,”
Virology, vol. 286, no. 2, pp. 456–465, 2003.
[11] J. F. Ridpath, “Practical signiﬁcance of heterogeneity among
BVDVstrains:impactofbiotype andgenotypeonU.S.control
programs,” Preventive Veterinary Medicine,v o l .7 2 ,n o .1 - 2 ,
pp. 17–30, 2005.
[12] B. Chul Ahn, P. H. Walz, and G. A. Kennedy, “Biotype,
genotype and clinical presentation associated with bovine
viraldiarrhea virus(BVDV)isolatesfromcattle,”International
Journal ofAppliedResearchinVeterinary Medicine,vol.3,no.4,
pp. 319–325, 2005.
[ 1 3 ]R .W .F u l t o n ,B .H e s s m a n ,B .J .J o h n s o ne ta l . ,“ E v a l u a t i o n
of diagnostic tests used for detection of bovine viral diarrhea
virus and prevalence of subtypes 1a, 1b, and 2a in persistently
infected cattle entering a feedlot,” Journal of the American
Veterinary Medical Association, vol. 228, no. 4, pp. 578–584,
2006.
[ 1 4 ]R .W .F u l t o n ,J .F .R i d p a t h ,S .O r ee ta l . ,“ B o v i n ev i r a ld i a r -
rhoea virus (BVDV) subgenotypes in diagnostic laboratory
accessions: distribution of BVDV1a, 1b, and 2a subgeno-
types,” Veterinary Microbiology, vol. 111, no. 1-2, pp. 35–40,
2005.
[15] M. Tajima and E. J. Dubovi, “Genetic and clinical analyses of
bovine viral diarrhea virus isolates from dairy operations in
the United States of America,” Journal of Veterinary Diagnostic
Investigation, vol. 17, no. 1, pp. 10–15, 2005.
[16] J. F. Evermann and J. F. Ridpath, “Clinical and epidemiologic
observationsofbovineviraldiarrhea virusinthenorthwestern
United States,” Veterinary Microbiology, vol. 89, no. 2-3,
pp. 129–139, 2002.
[17] S. R. Bolin and D. L. Grooms, “Origination and consequences
of bovine viral diarrhea virus diversity,” Veterinary Clinics of
North America. Food Animal Practice, vol. 20, no. 1, pp. 51–68,
2004.
[ 1 8 ]S .V i l c e k ,A .J .H e r r i n g ,J .A .H e r r i n g ,P .F .N e t t l e t o n ,J .P .
Lowings, and D. J. Paton, “Pestiviruses isolated from pigs,
cattleandsheepcanbeallocated intoatleastthree genogroups
using polymerase chain reaction and restriction endonuclease
analysis,” Archives of Virology, vol. 136, no. 3-4, pp. 309–323,
1994.
[ 1 9 ]S .V i l c e k ,D .J .P a t o n ,B .D u r k o v i ce ta l . ,“ B o v i n ev i r a ld i a r -
rhoea virus genotype 1 can be separated into at least eleven
genetic groups,” Archives of Virology, vol. 146, no. 1, pp. 99–
115, 2001.
[20] J. F. Everman and G. Barrington, “Clinical features,” in Bovine
Viral Diarrhea Virus: Diagnosis, Management, and Control,
S. M. Goyal and J. F. Ridpath, Eds., pp. 105–119, Blackwell,
Oxford, UK, 2005.
[21] C. Baule, G. Kulcsar, K. Belak et al., “Pathogenesis of primary
respiratory disease induced by isolates from a new genetic
cluster ofbovine viral diarrhea virus type I,” Journal of Clinical
Microbiology, vol. 39, no. 1, pp. 146–153, 2001.
[ 2 2 ] D .M .H a i n e s ,K .M .M a r t i n ,E .G .C l a r k ,G .K e eJ i m ,a n dE .D .
Janzen, “The immunohistochemicaldetection of Mycoplasma
bovis andbovineviraldiarrheavirusintissuesoffeedlot cattle
with chronic, unresponsive respiratory disease and/or arthri-
tis,” Canadian Veterinary Journal, vol. 42, no. 11, pp. 857–860,
2001.
[23] C. L. Waldner and R. I. Kennedy, “Associations between
health and productivity in cow-calf beef herds and persis-
tent infection with bovine viral diarrhea virus, antibodies
against bovine viral diarrhea virus, or antibodies against
infectious bovine rhinotracheitis virus in calves,” American
Journal of Veterinary Research, vol. 69, no. 7, pp. 916–927,
2008.6 Veterinary Medicine International
[ 2 4 ]R .W .F u l t o n ,J .F .R i d p a t h ,J .T .S a l i k ie ta l . ,“ B o v i n ev i r a l
diarrhea virus (BVDV) 1b: predominant BVDV subtype in
calveswithrespiratorydisease,”Canadian JournalofVeterinary
Research, vol. 66, no. 3, pp. 181–190, 2002.
[25] R.W .Fulton,J.F .Ridpath,A.W .Confer ,J.T .Saliki,L.J.Burge,
and M. E. Payton, “Bovine viral diarrhoea virus antigenic
diversity: impact on disease and vaccination programmes,”
Biologicals, vol. 31, no. 2, pp. 89–95, 2003.